Core Viewpoint - Kyndryl Holdings, Inc. is under investigation for its cash management procedures and disclosures following a shift from adjusted to reported free cash flow, raising concerns about the integrity of its financial reporting [1] Group 1: Financial Reporting Changes - Kyndryl's CFO announced a transition to highlighting free cash flow instead of adjusted free cash flow, suggesting improved financial maturity as the gap between GAAP and non-GAAP metrics had narrowed [1] - The February 9, 2026 disclosure indicated that Kyndryl is reviewing its cash management procedures, which may reveal "material weaknesses" in internal controls [1] Group 2: Implications of the Investigation - If the investigation finds that previously reported cash-flow figures were misstated, it could undermine the company's capital-allocation strategy, including a $400 million increase in the share-repurchase program [1] - The company's reported free cash flow of $22 million for Q2 FY2026 and a cash balance of $1.3 billion as of September 30 are now subject to scrutiny under the ongoing investigation [1]

Financial Data and Key Metrics Changes - In 2025, the company achieved record underwriting profit of $67 million, up from $9 million in 2024, and net investment income increased by nearly 20% [6][7] - Full-year operating earnings per share improved by 80%, reaching $4.60, while book value per share grew by more than $6 to $36.88 [6][10] - The annual combined ratio improved to 94.8%, reflecting ongoing improvements in the underlying loss ratio, catastrophe loss ratio, and expense ratio [7][10] Business Line Data and Key Metrics Changes - The core commercial business, including small business, middle market, and construction, saw the strongest growth, contributing to a 9% increase in net written premium to over $1.3 billion [7][12] - Specialty E&S net written premium grew at a double-digit pace, while the surety business also delivered double-digit growth for the quarter and full year [15][16] - Rate increases moderated to 4.8% for the quarter, indicating a more competitive environment, particularly in property lines [13] Market Data and Key Metrics Changes - The company experienced a competitive market environment, particularly in property, but maintained a disciplined approach to underwriting and pricing [13][26] - The renewal of reinsurance treaties was successful, resulting in lower ceded margins and improved terms, despite exposure-adjusted rate decreases in major programs [19] Company Strategy and Development Direction - The company is focused on disciplined, solution-oriented underwriting, aiming for continued profitable growth and improved operational efficiency through strategic investments in technology [8][11] - The board of directors declared a 25% increase in the quarterly cash dividend, reflecting confidence in future financial performance and commitment to shareholder value [11][22] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's positioning for 2026, emphasizing the successful transformation since late 2022 and the potential for sustainable growth [9][42] - The company is committed to maintaining a conservative posture with reserves to protect the balance sheet and is confident in achieving mid-teens return on equity targets [10][26] Other Important Information - The company reported a fourth-quarter net income of $1.45 per diluted share, with adjusted operating income of $1.50 per diluted share [21] - The expense ratio improved to 35.7%, with expectations for gradual reduction over time as growth continues [21][30] Q&A Session Summary Question: Current pricing expectations in a competitive market - Management acknowledged increased competition but maintained that pricing remains rational and attractive, with a focus on disciplined risk selection [25][26] Question: Long-term target for underwriting expense ratio - The company targets a run rate of about 35% for the expense ratio, with expectations for gradual reduction as growth continues [29][30] Question: Dynamics affecting profitability in the student insurance business - Management noted increased competition affecting rates and terms but emphasized disciplined underwriting and long-term commitments to maintain profitability [34][35] Question: Profitability issues in the other liability line - Management identified pressure on profitability in the umbrella line due to large losses but is taking a conservative approach to pricing and reserves [36][37] Question: Impact of nuclear verdicts on umbrella profitability - Management clarified that while social inflation impacts the portfolio, they have not seen significant nuclear verdicts affecting their business [38][39]

Financial Data and Key Metrics Changes - First quarter revenue was $210 million, up 5% year-over-year, driven by a 17% increase in the industrial segment revenue [5][17] - Non-GAAP gross margin was 34%, at the high end of guidance, benefiting from a favorable product sales mix [6][20] - Non-GAAP EBITDA was $29 million, up 12% compared to the same quarter last year [7] - Non-GAAP EPS in the first quarter was $0.19, up from $0.10 in the previous year [7][22] Business Line Data and Key Metrics Changes - Medical segment revenue was stable year-over-year at $145 million, while industrial segment revenue increased to $65 million, representing 69% and 31% of total revenues respectively [17] - The industrial segment showed broad-based strength, particularly in cargo security inspection systems and components [9][16] - Demand for X-ray sources and digital detectors in the medical segment remained strong, particularly in high-end CT [7][8] Market Data and Key Metrics Changes - Americas revenue grew 17%, driven by strength in the industrial segment related to cargo systems [18] - EMEA revenue rose 7%, while APAC revenue decreased by 7% year-over-year [18] - Sales volume to China remained steady, contributing 17% of total revenues, indicating resilience in the healthcare market position [18] Company Strategy and Development Direction - The company is focusing on a modality-based approach to enhance customer engagement and drive long-term recurring revenue [12] - Increased collaboration with customers is aimed at addressing complex inspection problems using X-ray imaging in real-time manufacturing [9][12] - The company is investing in innovation and technology integration into next-generation imaging systems, particularly in the medical segment [26] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the medical segment, indicating that previous headwinds are behind them, with strong demand for CT continuing [30][31] - The industrial segment's order pipeline and customer engagement are strong, particularly in food inspection and security screening [32] - Management noted that customer interactions at RSNA indicated a shift towards new product development and commercialization [15][34] Other Important Information - The company modified its non-GAAP policy to exclude gains and losses from equity method investments, reflecting a strategic shift [19] - Inventory increased by $29 million to $328 million, driven by anticipated demand across the industrial segment [22][23] - The company ended the quarter with cash and marketable securities of $126 million, down $30 million from the previous quarter [23] Q&A Session Summary Question: General outlook for the business - Management indicated optimism about both medical and industrial segments, with strong order activity and customer engagement [29][30] Question: Progress on India operations - Management confirmed that the India factory is operational, producing detectors and tubes, with positive customer feedback regarding local manufacturing [36][37] Question: Guidance for the next quarter - Management provided guidance for revenues between $210 million and $225 million, with non-GAAP EPS expected between $0.15 and $0.25 [24][25] Question: Inventory increase explanation - Management explained that the inventory increase is intentional to prepare for cargo systems ramp-up and qualification cycles for products in India [80][81] Question: Refinancing plans - Management is working on refinancing high-yield debt due in October 2027, aiming to complete it before October 2026 [82][84]

Financial Data and Key Metrics Changes - First quarter revenue was $210 million, up 5% year-over-year, driven by a 17% increase in industrial segment revenue [5][15] - Non-GAAP gross margin was 34%, at the high end of guidance, benefiting from a favorable product sales mix [5][17] - Non-GAAP EBITDA was $29 million, up 12% compared to the same quarter last year [6] - Non-GAAP EPS in the first quarter was $0.19, up from $0.10 in the previous year [6][18] - GAAP gross margin was 33%, down 100 basis points year-over-year [16] Business Line Data and Key Metrics Changes - Medical segment revenue was stable year-over-year at $145 million, while industrial segment revenue increased to $65 million, representing 69% and 31% of total revenues respectively [15] - Medical segment performance was stable, with strong demand for X-ray sources and digital detectors [6][8] - Industrial segment delivered a 17% growth, driven by cargo security inspection systems and components [5][15] Market Data and Key Metrics Changes - Americas revenue grew 17%, driven by strength in the industrial segment [15] - EMEA revenue rose 7%, while APAC revenue decreased by 7% year-over-year [15] - Sales volume to China remained steady, contributing 17% of total revenues [15] Company Strategy and Development Direction - The company is focusing on a modality-based approach to enhance customer engagement and drive long-term recurring revenue [10][11] - Increased collaboration with customers is aimed at addressing complex inspection problems using X-ray imaging [8][10] - The company is investing in innovation and technology integration into next-generation imaging systems [23] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the medical segment, indicating that previous headwinds are behind them and customer order activity is strong [27] - The industrial segment's order pipeline remains robust, particularly in food inspection and security screening [27] - Management noted that customer engagement at RSNA was significantly more positive compared to previous years, indicating a shift towards new product development [29][30] Other Important Information - The company modified its non-GAAP policy to exclude gains and losses from equity method investments, reflecting a strategic shift [16][17] - Inventory increased by $29 million to $328 million, driven by anticipated demand and qualification cycles for new products [19][72] Q&A Session Summary Question: General outlook for the current environment - Management indicated that headwinds faced in previous years are behind them, with strong order activity in the medical segment and stability in China [27][28] Question: Progress on India operations - Management confirmed that the India factory is operational, producing detectors and tubes, with strong customer interest in locally sourced products [32][34] Question: Guidance for the upcoming quarter - Management provided guidance for Q2 revenues between $210-$225 million and non-GAAP EPS between $0.15-$0.25, citing a conservative approach [21][22] Question: Cargo orders and industrial segment growth - Management noted strong traction in cargo systems, with potential for double-digit growth in the industrial segment, contingent on customer demand [42][45] Question: Inventory increase and future plans - Management explained that the inventory increase is intentional to support cargo systems ramp-up and qualification cycles in India, with plans to normalize inventory levels [70][72] Question: Refinancing plans - Management is working on refinancing high-yield debt due in October 2027, aiming to complete it before October 2026 [73][74]

Core Insights - onsemi (ON) reported Q4 2025 non-GAAP earnings of 64 cents per share, exceeding Zacks Consensus Estimate by 3.23% but down 32.6% year over year [1] - Revenues of $1.53 billion fell short of Zacks Consensus Estimate by 0.19% and decreased 11.2% year over year [1] - ON shares declined by 4.92% at the time of reporting [1] Q4 Performance Details - Power Solutions Group revenues were $724.2 million, contributing 47.3% to total revenues, down 10.5% year over year [2] - Analog & Mixed Group revenues were $556.3 million, accounting for 36.4% of revenues, down 8.9% year over year [2] - Intelligent Sensing Group revenues were $249.6 million, making up 16.3% of revenues, down 17.5% year over year [2] Financial Metrics - Non-GAAP gross margin was 38.2%, compared to 45.3% in the same quarter last year [3] - Non-GAAP operating expenses decreased by 12.2% year over year to $282 million, representing a 20 basis points decrease as a percentage of revenues [3] - Non-GAAP operating margin was 19.8%, down from 26.7% in the year-ago quarter [3] Balance Sheet & Cash Flow - As of December 31, 2025, cash and cash equivalents were $2.55 billion, down from $2.87 billion as of October 3, 2025 [4] - Long-term debt was $2.98 billion, a decrease of 11.1% sequentially [4] - Q4 2025 cash flow from operations was $554.5 million, up from $418.7 million in the previous quarter [4] - Free cash flow was $485.4 million, compared to $372.4 million in the previous quarter [4] Q1 Guidance - For Q1 2026, onsemi expects revenues between $1.44 billion and $1.54 billion [5] - Non-GAAP gross margin is projected to be in the range of 37.5-39.5% [5] - Non-GAAP operating expenses are expected to be between $285 million and $300 million [5] - Non-GAAP earnings are anticipated to be between 56 cents and 66 cents per share [5] Market Position - ON currently holds a Zacks Rank 3 (Hold) [6] - Competitors such as Analog Devices (ADI), Applied Materials (AMAT), and MKS (MKSI) are noted as better-ranked stocks in the broader Zacks Computer and Technology sector [8][9]

4th Quarter 2025 Investment Thesis February 9, 2026 Slides 5 — 18 Executive Summary Forward-Looking Statements These materials contain certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"), Section 27A of the Securities Act of 1933 and Rule 175 promulgated thereunder, and Section 21E of the Securities Exchange Act of 1934 and Rule 3b-6 promulgated thereunder, notwithstanding that such statements are not specifically identified as such. In ...

Q3 Fiscal 2026 Financial Results February 5, 2026 Management Presenters Scott Barbour President and Chief Executive Officer Scott Cottrill Executive Vice President, Chief Financial Officer Craig Taylor Forward Looking Statements Certain statements in this press release may be deemed to be forward -looking statements. These statements are not historical fac ts but rather are based on the Company's current expectations, estimates and projections regarding the Company's business, operations and other factors r ...

Core Viewpoint - Ingredion Incorporated reported record performance for the year 2025, driven by strong results in the Texture & Healthful Solutions segment and solid performance in the Latin America Food & Industrial Ingredients segment, although operations in the U.S./Canada segment faced challenges [1] Financial Performance - For Q4 2025, reported diluted EPS was $2.56, up from $1.43 in Q4 2024, while adjusted diluted EPS was $2.53 compared to $2.63 in Q4 2024 [2][4] - Full-year 2025 reported and adjusted EPS were $11.18 and $11.13, respectively, compared to $9.71 and $10.65 in 2024 [4] - Operating income for Q4 2025 was $220 million, a 36% increase from $162 million in Q4 2024, while full-year operating income rose 15% to $1,016 million [6][41] Segment Performance - The Texture & Healthful Solutions segment reported Q4 2025 net sales of $591 million, a 2% increase from Q4 2024, while full-year sales were $2,397 million, up 1% [9][41] - Latin America Food & Industrial Ingredients segment achieved Q4 2025 net sales of $587 million, a 1% increase, but full-year sales decreased by 4% to $2,341 million [12][41] - U.S./Canada Food & Industrial Ingredients segment saw Q4 2025 net sales drop to $463 million, a 9% decline, with full-year sales down 7% to $2,013 million [14][41] Cash Flow and Capital Management - Operating cash flow for 2025 was $944 million, down from $1,436 million in 2024, reflecting increased working capital investments [19][39] - The company returned $435 million to shareholders through dividends and share repurchases in 2025 [20] 2026 Outlook - For 2026, the company expects reported and adjusted EPS to range between $11.00 and $11.80, with net sales anticipated to grow in the low single digits to mid-single digits [21][22] - The company forecasts operating income to see low single-digit increases, driven by volume growth but partially offset by pricing mix factors [21]

February 2026 INVESTOR PRESENTATION 1 DISCLAIMER Forward-looking statements Some of the statements contained in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve risk, assumptions and uncertainties, such as statements of our plans, objectives, expectations, intentions and forecasts. These forward- looking statements reflect our views with respect to fu ...

Core Insights - Lumentum (LITE) reported strong financial results for Q2 fiscal 2026, with non-GAAP earnings of $1.67 per share, exceeding the Zacks Consensus Estimate by 18.68% and showing a significant increase from 42 cents in the same quarter last year [2][9] - Non-GAAP revenues reached $665.5 million, surpassing the consensus mark by 1.85%, and reflecting a 24.7% sequential increase and a 65.5% year-over-year growth, indicating robust demand for optical components and systems [2][9] Financial Performance - The Components segment accounted for 66.7% of total revenues, increasing 68.3% year-over-year to $443.7 million, while System revenues contributed 33.3% and rose 60.1% year-over-year to $221.8 million [3][9] - Non-GAAP gross margin improved to 42.5% from 32.3% in the previous year, and non-GAAP operating margin expanded to 25.2% from 7.9% year-over-year, reflecting a better cost structure [4][9] Balance Sheet - As of December 27, 2025, Lumentum's cash and cash equivalents, including short-term investments, were $1.15 billion, slightly up from $1.12 billion as of September 27, 2025 [5] Future Guidance - For Q3 fiscal 2026, Lumentum anticipates non-GAAP revenues between $780 million and $830 million, with an expected non-GAAP operating margin of 30% to 31% and diluted earnings per share projected between $2.15 and $2.35 [6] Market Position - Lumentum holds a Zacks Rank 1 (Strong Buy), indicating a favorable outlook compared to other stocks in the Computer & Technology sector, such as Ciena, Microchip Technology, and MKS, which also have a Zacks Rank 1 [7]